LUMO insider transactions
Lumos Pharma Inc. (LUMO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for LUMO
- Chief Executive Officer Hawkins Richard J returned 757,562 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Director Zoth Lota S. returned 2,187 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Chief Scientific Officer Mckew John C. returned 13,153 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Director Johnson Chad Allen returned 1,076 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Director Van Es-Johansson An returned 1,100 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Director Raffin Thomas A. returned 9,406 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Chief Medical Officer Pitukcheewanont Pisit Duke returned 16,836 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Director Lalande Kevin M. returned 731,522 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Chief Business Officer Schuchart Aaron returned 8,179 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- General Counsel Powers Bradley J returned 6,334 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Director Mccracken Joseph S returned 15,721 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Chief Financial Officer Lawley Lori D returned 12,284 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Chief Scientific Officer Mckew John C. sold $6,426 worth of shares (3,407 units at $1.89), decreasing direct ownership by 21% to 12,653 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Chief Scientific Officer Mckew John C. covered exercise/tax liability with 1,593 shares, decreasing direct ownership by 9% to 16,060 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Chief Financial Officer Lawley Lori D covered exercise/tax liability with 229 shares, decreasing direct ownership by 2% to 12,284 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Chief Medical Officer Pitukcheewanont Pisit Duke covered exercise/tax liability with 274 shares, decreasing direct ownership by 2% to 16,836 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Van Es-Johansson An4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Mccracken Joseph S4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Johnson Chad Allen4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Zoth Lota S.4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Raffin Thomas A.4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Lalande Kevin M.4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Pitukcheewanont Pisit Duke covered exercise/tax liability with 320 shares, decreasing direct ownership by 2% to 16,610 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Powers Bradley J was granted 900 shares and covered exercise/tax liability with 342 shares, increasing direct ownership by 10% to 6,307 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Lawley Lori D was granted 1,000 shares and covered exercise/tax liability with 274 shares, increasing direct ownership by 6% to 12,513 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Pitukcheewanont Pisit Duke was granted 6,000 shares, increasing direct ownership by 55% to 16,930 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Mckew John C. was granted 2,000 shares, covered exercise/tax liability with 1,036 shares and sold $6,144 worth of shares (2,214 units at $2.77), decreasing direct ownership by 7% to 17,153 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Hawkins Richard J was granted 4,500 shares and covered exercise/tax liability with 1,522 shares, increasing direct ownership by 0.40% to 753,093 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Schuchart Aaron was granted 1,000 shares, increasing direct ownership by 18% to 6,679 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Mckew John C. sold $1,328 worth of shares (438 units at $3.03), decreasing direct ownership by 2% to 18,403 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Mckew John C. covered exercise/tax liability with 366 shares, decreasing direct ownership by 2% to 18,841 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Hawkins Richard J covered exercise/tax liability with 690 shares, decreasing direct ownership by 0.09% to 750,115 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Lawley Lori D covered exercise/tax liability with 215 shares, decreasing direct ownership by 2% to 11,787 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Schuchart Aaron covered exercise/tax liability with 202 shares, decreasing direct ownership by 3% to 5,679 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- Powers Bradley J covered exercise/tax liability with 240 shares, decreasing direct ownership by 4% to 5,749 units (SEC Form 4)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- New insider Pitukcheewanont Pisit Duke claimed ownership of 10,930 shares (SEC Form 3)3 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Lawley Lori D covered exercise/tax liability with 229 shares, decreasing direct ownership by 2% to 11,502 units4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Mckew John C. covered exercise/tax liability with 1,593 shares and sold $10,919 worth of shares (3,407 units at $3.21), decreasing direct ownership by 21% to 18,707 units4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Zoth Lota S.4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Van Es-Johansson An4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Raffin Thomas A.4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Mccracken Joseph S4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Lalande Kevin M.4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Johnson Chad Allen4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Powers Bradley J4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Mckew John C.4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Lawley Lori D4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4 filed by Hawkins Richard J4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Schuchart Aaron was granted 1,000 shares and covered exercise/tax liability with 104 shares, increasing direct ownership by 20% to 5,381 units to satisfy tax liability4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Powers Bradley J was granted 900 shares and covered exercise/tax liability with 131 shares, increasing direct ownership by 14% to 6,331 units (for withholding tax)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Mckew John C. was granted 2,000 shares, covered exercise/tax liability with 206 shares and sold $1,550 worth of shares (439 units at $3.53) as part of a pre-agreed trading plan, increasing direct ownership by 5% to 26,457 units (withholding obligation)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Lawley Lori D was granted 1,000 shares and covered exercise/tax liability with 114 shares, increasing direct ownership by 8% to 11,505 units (for tax liability)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Karpf David B was granted 1,000 shares and covered exercise/tax liability with 36 shares, increasing direct ownership by 13% to 8,294 units to cover taxes4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Hawkins Richard J was granted 4,500 shares and covered exercise/tax liability with 416 shares, increasing direct ownership by 0.55% to 752,327 units (tax liability)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Mccracken Joseph S bought $20,120 worth of shares (4,000 units at $5.03), increasing direct ownership by 34% to 15,721 units4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Hawkins Richard J bought $21,402 worth of shares (2,422 units at $8.84)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Hawkins Richard J bought $17,857 worth of shares (2,047 units at $8.72)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Karpf David B covered exercise/tax liability with 570 shares, decreasing direct ownership by 7% to 7,330 units (tax liability)4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Raffin Thomas A. bought $9,729 worth of shares (1,150 units at $8.46), increasing direct ownership by 14% to 9,406 units4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
- SEC Form 4: Mccracken Joseph S bought $27,262 worth of shares (3,170 units at $8.60), increasing direct ownership by 37% to 11,721 units4 - LUMOS PHARMA, INC. (0001126234) (Issuer)